A carregar...

Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer

Liangliang Bai,1,2 Pengfei Zhang,1,2 Kexun Zhou,1,2 Weiting Liao,1,2 Qiu Li1,2 1Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of China; 2West China Biomedical Big Data Center, Sichuan University, Chengdu,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bai L, Zhang P, Zhou K, Liao W, Li Q
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2019-12-01
Colecção:Cancer Management and Research
Assuntos:
Acesso em linha:https://www.dovepress.com/cost-effectiveness-analysis-of-first-line-cetuximab-plus-leucovorin-fl-peer-reviewed-article-CMAR
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!